Skip to content

Clinical trials

Macular Degeneration trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Country / region: Australia Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20073
20085
20091
20101
20114
20131
20144
20152
20171
20182
20193
20205
20215
20223
20232
20242
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Recruiting11
Terminated10
Not yet recruiting2
Active, not recruiting2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan7
Center for Eye Research Australia6
Bayer4
Novartis Pharmaceuticals4
GlaxoSmithKline3
Genentech, Inc.2
Gyroscope Therapeutics Limited2
Ionis Pharmaceuticals, Inc.2
Janssen Research & Development, LLC2
Ophthotech Corporation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration56
Geographic Atrophy18
Choroidal Neovascularization12
Retinal Diseases8
Wet Macular Degeneration7
Retinal Degeneration6
Eye Diseases5
Vision Disorders3
Anetoderma2
Diabetic Retinopathy2

Trials

Showing 76 to 56 of 56. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.